Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Gild save search
Gilead Sciences Publishes 2023 ESG Impact Report
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
gilead report sciences impact esg
Citius Pharmaceuticals Announces Addition of City of Hope to UMN's Phase 1 Trial of LYMPHIR in Combination with CAR-T for the Treatment of B-Cell Lymphoma
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
FNCTF | News | $11.0354 320
|
Communications
|
| O: -100.0%
H: NaN%
C: Infinity%
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: 0.5%
H: 0.83%
C: 0.28%
CTXR | $0.779 -3.29% 610K
|
Health Technology
|
| O: 2.33%
H: 2.28%
C: -4.23%
hope treatment pharmaceuticals city for car-t trial
Leap Therapeutics Announces $40 Million Private Placement
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
LPTX | $2.88 -2.7% 9.3K
|
Health Technology
|
| O: 15.13%
H: 25.43%
C: -11.0%
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: 0.5%
H: 0.83%
C: 0.28%
million leap therapeutics
Gilead Sciences to Release First Quarter 2024 Financial Results on Thursday, April 25, 2024
Published: 2024-04-08 (Crawled : 23:00) - biospace.com/
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: -0.76%
H: 0.72%
C: 0.54%
gilead first sciences financial results
RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights
Published: 2024-04-08 (Crawled : 13:30) - prnewswire.com
RDHL | $0.425 1.0% 120K
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: -1.5%
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: -0.76%
H: 0.72%
C: 0.54%
biopharma results
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
Published: 2024-04-02 (Crawled : 20:00) - globenewswire.com
RMD | $178.77 0.65% 260K
|
Health Technology
|
| O: 0.88%
H: 1.64%
C: 0.03%
LUNG | $7.49 -0.13% 45K
|
Health Technology
|
| O: 0.59%
H: 1.64%
C: -7.13%
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: -0.12%
H: 0.24%
C: -1.54%
financial
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-04-01 (Crawled : 20:00) - globenewswire.com
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: -0.08%
H: 0.04%
C: -1.0%
business year pipeline therapeutics financial results
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published: 2024-03-29 (Crawled : 18:00) - prnewswire.com
BMY | $48.56 0.54% 1.8M
|
Health Technology
| Email alert
Add to watchlist
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 600K
|
Health Technology
| Email alert
Add to watchlist
AMGN | $265.32 0.98% 550K
|
Health Technology
| Email alert
Add to watchlist
GMAB | $28.67 1.2% 41K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.34 2.09% 620K
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | $93.815 1.35% 410K
|
Health Technology
| Email alert
Add to watchlist
GNMSF | $290.38 220
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $164.91 0.15% 1.2M
|
Health Technology
| Email alert
Add to watchlist
research global leukemia therapeutics market
Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights
Published: 2024-03-28 (Crawled : 20:00) - globenewswire.com
ASMB | $13.33 6.4K
|
Health Technology
| Email alert
Add to watchlist
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
| Email alert
Add to watchlist
year financial results
Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing
Published: 2024-03-28 (Crawled : 11:00) - globenewswire.com
XLO | $1.24 -3.13% 28K
|
Professional, Scientific, and T...
|
| O: 200.47%
H: 0.52%
C: -43.75%
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: 0.33%
H: 0.85%
C: 0.0%
million therapeutics
Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program
Published: 2024-03-28 (Crawled : 11:00) - globenewswire.com
XLO | $1.24 -3.13% 28K
|
Professional, Scientific, and T...
|
| O: 200.47%
H: 0.52%
C: -43.75%
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: 0.33%
H: 0.85%
C: 0.0%
il-12 license program agreement
Everest Medicines Announces Financial Results for Full Year Ended December 31, 2023
Published: 2024-03-27 (Crawled : 23:00) - prnewswire.com
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: 0.33%
H: 0.85%
C: 0.0%
year financial results
Hepatitis B and C diagnostics market size to increase by USD 2.05 billion, Technavio
Published: 2024-03-27 (Crawled : 14:30) - prnewswire.com
DHR | $235.56 -0.34% 390K
|
Health Technology
|
| O: 0.56%
H: 0.16%
C: -0.43%
ABT | News | $107.24 1.87% 2M
|
Health Technology
|
| O: 1.48%
H: 0.0%
C: 0.0%
VIR | $8.02 0.75% 140K
|
Health Technology
|
| O: 0.4%
H: 2.3%
C: 0.9%
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: 0.7%
H: 0.19%
C: 0.12%
hepatitis diagnostics market
Gilead Sciences Announces Completion of Acquisition of CymaBay
Published: 2024-03-22 (Crawled : 22:00) - biospace.com/
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: 0.03%
H: 0.16%
C: -0.68%
acquisition sciences
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
Published: 2024-03-22 (Crawled : 11:00) - globenewswire.com
HOOK | $0.7649 88K
|
Health Technology
|
| O: 3.58%
H: 0.0%
C: -5.19%
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: 0.03%
H: 0.16%
C: -0.68%
pharma business year financial results
Global Neutropenia Market Poised to Reach USD 5.86 Billion by 2028, Amid Rising Cancer Incidence and Advancements in Treatment Options
Published: 2024-03-18 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
BAX | $39.945 0.74% 430K
|
Health Technology
|
| O: 0.02%
H: 1.03%
C: 0.96%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -1.51%
H: 0.0%
C: 0.0%
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: 0.11%
H: 0.59%
C: 0.1%
BIIB | $191.45 0.49% 310K
|
Health Technology
|
| O: -0.48%
H: 0.31%
C: 0.13%
reach cancer treatment global market
Gilead and Merus Announce Collaboration to Discover Novel Antibody-Based Trispecific T-Cell Engagers
Published: 2024-03-06 (Crawled : 15:30) - biospace.com/
MRUS | $40.48 0.03% 180K
|
Health Technology
|
| O: 0.06%
H: 1.66%
C: -2.56%
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: -0.15%
H: 0.6%
C: -0.34%
t-cell collaboration
Gilead Sciences CEO on Company's Evolution and Commitment to the Bay Area
Published: 2024-03-05 (Crawled : 14:30) - biospace.com/
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: 0.21%
H: 0.84%
C: 0.81%
ceo bay sciences
CymaBay Reports Fourth Quarter and Year Ended December 31, 2023 Financial Results and Provides Corporate Update
Published: 2024-02-28 (Crawled : 22:00) - globenewswire.com
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: 0.03%
H: 0.26%
C: -0.85%
CBAY | $32.48 0.03% 8.4M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
year update financial results
Arcellx Provides Fourth Quarter and Year-End 2023 Financial Results and Business Highlights
Published: 2024-02-28 (Crawled : 21:00) - prnewswire.com
ACLX | $53.29 -2.22% 110K
|
|
| O: 3.09%
H: 0.94%
C: -5.16%
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: 0.03%
H: 0.26%
C: -0.85%
business financial results
Gainers vs Losers
| 79% | 21% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.0606 68.33% 250M
|
NVFY | $3.45 63.51% 20M
|
Consumer Durables
ZCMD | $1.98 36.55% 27M
|
Commercial Services
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
PAPL | $2.07 26.22% 550K
|
RWOD | $10.08 26.05% 5.6M
|
n/a
AULT | $0.304 25.57% 47M
|
Manufacturing
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.